Skip to main content
  • Advertise
    Want to Advertise with Us?
    Conquer welcomes advertising and sponsorship collaborations with reputable companies offering high-quality products and services to people affected by cancer.
  • Affiliated Brands
    Academy of Oncology Nurse & Patient Navigators
    The Academy of Oncology Nurse & Patient Navigators (AONN+) is the largest national specialty organization dedicated to improving patient care and quality of life by defining, enhancing, and promoting the role of oncology nurse and patient navigators. Our organization of over 8,900 members was founded in May 2009 to provide a network for all professionals involved and interested in patient navigation and survivorship care services to better manage the complexities of the cancer care treatment continuum for their patients. We view our organization as one consisting of “professional patient advocates” and, to that end, we support and serve our members.
    Journal of Oncology Navigation & Survivorship
    The Journal of Oncology Navigation & Survivorship (JONS) promotes reliance on evidence-based practices in navigating patients with cancer and their caregivers through diagnosis, treatment, and survivorship. JONS also seeks to strengthen the role of nurse and patient navigators in cancer care by serving as a platform for these professionals to disseminate original research findings, exchange best practices, and find support for their growing community.
    The Oncology Nurse-APN/PA
    The Oncology Nurse-APN/PA (TON) provides coverage of the wide spectrum of oncology-related events, trends, news, therapeutics, diagnostics, organizations, and legislation that directly affect hematology/oncology nurses and advanced practitioners involved in healthcare delivery and product utilization. The scope and coverage include a unique presentation of news and events that are shaping the care of patients with cancer.
  • Healthcare Providers
  • Contribute

Drugs for Leukemia

  • Acute Lymphoblastic Leukemia (ALL)

    Arranon (nelarabine)

    Drug company: Novartis
    800-282-7630

    Novartis Patient Assistance NOW Oncology offers 1 financial assistance program for patients using Arranon:

    Novartis Patient Assistance Foundation

    Besponsa (inotuzumab ozogamicin) Injection

    Drug company: Pfizer
    877-744-5675

    Pfizer Oncology Together offers 1 financial assistance program for patients using Besponsa:

    Pfizer Patient Assistance Program

    Blincyto (blinatumomab)

    Drug company: Amgen
    888-427-7478

    Amgen Assist 360 offers 2 financial assistance programs for patients using Blincyto:

    Amgen FIRST STEP Co-Pay Program

    Amgen Safety Net Foundation

    Gleevec (imatinib mesylate) Tablets

    Drug company: Novartis
    800-282-7630

    Novartis Patient Assistance NOW Oncology offers 2 financial assistance programs for patients using Gleevec:

    Novartis Oncology Universal Co-Pay Program

    Novartis Patient Assistance Foundation

    Iclusig (ponatinib) Tablets

    Drug company: Takeda Oncology
    844-817-6468

    Takeda Oncology offers 2 financial assistance programs for patients using Iclusig:

    Takeda Oncology Co-Pay Assistance Program

    Takeda Oncology Patient Assistance Program

    Kymriah (tisagenlecleucel)

    Drug company: Novartis
    800-282-7630

    Novartis Patient Assistance NOW offers 1 financial assistance program for patients using Kymriah:

    Kymriah Cares

    Rylaze (asparaginase erwinia chrysanthemi [recombinant]-rywn) Injection

    Drug company: Jazz Pharmaceuticals
    833-533-5299

    JazzCares offers 2 financial assistance programs for patients using Rylaze:

    JazzCares Copay Savings Card

    JazzCares Patient Assistance Program

    Sprycel (dasatinib) Tablets

    Drug company: Bristol Myers Squibb
    800-861-0048

    Bristol Myers Squibb Access Support offers 3 financial assistance programs for patients using Sprycel:

    Co-Pay Assistance Program

    Sprycel 30-Day Trial Offer

    Bristol Myers Squibb Patient Assistance Foundation

    Tecartus (brexucabtagene autoleucel)

    Drug company: Kite Pharma
    844-454-5483

    Kite Pharma offers 1 financial assistance program for patients who have been prescribed Tecartus:

    Kite Konnect

  • Acute Myeloid Leukemia (AML)

    Daurismo (glasdegib) Tablets

    Drug company: Pfizer
    877-744-5675

    Pfizer Oncology Together offers 2 financial assistance programs for patients using Daurismo:

    Pfizer Oncology Together Co-Pay Savings Program

    Pfizer Patient Assistance Program

    Idamycin PFS (idarubicin hydrochloride)

    Drug company: Pfizer
    877-744-5675

    Pfizer Oncology Together offers 1 financial assistance program for patients using Idamycin PFS:

    Pfizer Patient Assistance Program

    Idhifa (enasidenib) Tablets

    Drug company: Bristol Myers Squibb
    800-861-0048

    Bristol Myers Squibb Access Support offers 2 financial assistance programs for patients using Idhifa:

    BMS Oncology Co-Pay Assistance Program

    Bristol Myers Squibb Patient Assistance Foundation

    Mylotarg (gemtuzumab ozogamicin) Injection

    Drug company: Pfizer
    877-744-5675

    Pfizer Oncology Together offers 1 financial assistance program for patients using Mylotarg:

    Pfizer Patient Assistance Program

    Onureg (azacitidine) Tablets

    Drug company: Bristol Myers Squibb
    800-861-0048

    Bristol Myers Squibb Access Support offers 2 financial assistance programs for patients who have been prescribed Onureg:

    BMS Oncology Co-Pay Assistance Program

    Bristol Myers Squibb Patient Assistance Foundation

    Rezlidhia (olutasidenib) Capsules

    Drug company: Rigel and Forma Therapeutics, Inc
    800-983-1329

    Rigel and Forma Therapeutics, Inc offer 2 financial assistance programs for patients using Rezlidhia:

    Rigel Onecare

    Rezlidhia Copay Assistance

    Rydapt (midostaurin) Capsules

    Drug company: Novartis
    800-282-7630

    Novartis Patient Assistance NOW Oncology offers 2 financial assistance programs for patients using Rydapt:

    Novartis Oncology Universal Co-pay Program

    Novartis Patient Assistance Foundation

    Tibsovo (ivosidenib) Tablets

    Drug company: Servier Pharmaceuticals
    844-409-1141

    Servier Pharmaceuticals offers 2 financial assistance programs for patients using Tibsovo:

    Tibsovo Co-Pay Program

    Patient Assistance Program

    Venclexta (venetoclax) Tablets

    Drug company: AbbVie/Genentech
    866-422-2377

    AbbVie and Genentech offer 2 financial assistance programs for patients using Venclexta:

    Genentech Oncology Co-pay Assistance Program

    Genentech Patient Foundation

    Vyxeos (daunorubicin & cytarabine) Liposome for Injection

    Drug company: Jazz Pharmaceuticals
    833-533-5299

    JazzCares offers 2 financial assistance programs for patients who are prescribed Vyxeos:

    JazzCares Copay Savings Card

    JazzCares Patient Assistance Program

    Xospata (gilteritinib) Tablets

    Drug company: Astellas
    844-632-9272

    Astellas offers 3 financial assistance programs for patients using Xospata:

    Xospata Patient Savings Program

    Xospata Quick Start+ Program

    Astellas Patient Assistance Program

    Zarxio (filgrastim-sndz) Injection

    Drug company: Sandoz
    844-726-3691

    Sandoz One Source offers 1 financial assistance program for patients using Zarxio:

    Sandoz One Source Commercial Co-Pay Program

  • Chronic Lymphocytic Leukemia (CLL)

    Arzerra (ofatumumab)

    Drug company: Novartis
    800-282-7630

    Novartis Patient Assistance NOW Oncology offers 1 financial assistance program for patients using Arzerra:

    Novartis Patient Assistance Foundation

    Bendeka (bendamustine HCl) Injection

    Drug company: Teva
    888-587-3263

    Teva offers 1 financial assistance program for patients using Bendeka:

    Teva Cares Foundation Patient Assistance Program

    Calquence (acalabrutinib) Capsules

    Drug company: AstraZeneca
    844-275-2360

    AstraZeneca 360 offers 2 financial assistance programs for patients who are using Calquence:

    Calquence Co-pay Savings Program

    AZ&Me Prescription Savings Program

    Copiktra (duvelisib) Capsules

    Drug company: Secura Bio
    844-937-2872

    Secura Bio, through Secura Care, offers 3 financial assistance programs for patients using Copiktra:

    Co-Pay Program

    Patient Assistance Program

    Secura Bio Quickstart Program

    Gazyva (obinutuzumab)

    Drug company: Genentech
    866-422-2377

    Genentech Oncology offers 2 financial assistance programs for patients using Gazyva:

    Genentech Oncology Co-pay Assistance Program

    Genentech Patient Foundation

    Imbruvica (ibrutinib) Capsules/Tablets

    Drug company: Pharmacyclics
    888-968-7743

    Pharmacyclics’ You&i Support Program offers 2 financial assistance programs for patients using Imbruvica:

    Imbruvica Copay Card

    Johnson & Johnson Patient Assistance Foundation

    Rituxan (rituximab)

    Drug company: Genentech
    866-422-2377

    Genentech Oncology offers 2 financial assistance programs for patients using Rituxan:

    Genentech Oncology Co-pay Assistance Program

    Genentech Patient Foundation

    Rituxan Hycela (rituximab/hyaluronidase human) Injection

    Drug company: Genentech
    866-422-2377

    Genentech Oncology offers 2 financial assistance programs for patients using Rituxan Hycela:

    Genentech Oncology Co-pay Assistance Program

    Genentech Patient Foundation

    Venclexta (venetoclax) Tablets

    Drug company: Abbvie/Genentech
    866-422-2377

    AbbVie and Genentech offer 2 financial assistance programs for patients using Venclexta:

    Genentech Oncology Co-pay Assistance Program

    Genentech Patient Foundation

    Zydelig (idelalisib) Tablets

    Drug company: Gilead
    844-622-2377

    Zydelig AccessConnect offers 2 financial assistance programs for patients using Zydelig:

    Zydelig AccessConnect Copay Coupon Card

    Zydelig AccessConnect Patient Assistance Program

  • Chronic Myeloid Leukemia (CML)

    Bosulif (bosutinib) Tablets

    Drug company: Pfizer
    877-744-5675

    Pfizer Oncology Together offers 2 financial assistance programs for patients using Bosulif:

    Pfizer Oncology Together Co-Pay Savings Program

    Pfizer Patient Assistance Program

    Gleevec (imatinib mesylate) Tablets

    Drug company: Novartis
    800-282-7630

    Novartis Patient Assistance NOW Oncology offers 2 financial assistance programs for patients using Gleevec:

    Novartis Oncology Universal Co-pay Program

    Novartis Patient Assistance Foundation

    Iclusig (ponatinib) Tablets

    Drug company: Takeda Oncology
    844-817-6468

    Takeda Oncology offers 2 financial assistance programs for patients using Iclusig:

    Takeda Oncology Co-Pay Assistance Program

    Takeda Oncology Patient Assistance Program

    Scemblix (asciminib) Tablets

    Drug company: Novartis
    800-282-7630

    Novartis Patient Assistance NOW Oncology offers 3 financial assistance programs for patients using Scemblix:

    Novartis Oncology Universal Co-pay Program

    Scemblix 30-Day Voucher

    Novartis Patient Assistance Foundation

    Sprycel (dasatinib) Tablets

    Drug company: Bristol Myers Squibb
    800-861-0048

    Bristol Myers Squibb Access Support offers 3 financial assistance programs for patients using Sprycel:

    Co-Pay Assistance Program

    Sprycel 30-Day Trial Offer

    Bristol Myers Squibb Patient Assistance Foundation

    Synribo (omacetaxine) Injection

    Drug company: Teva
    888-587-3263

    Teva offers 1 financial assistance program for patients using Synribo:

    Teva Cares Foundation Patient Assistance Program

    Tasigna (nilotinib) Capsules

    Drug company: Novartis
    800-282-7630

    Novartis Patient Assistance NOW Oncology offers 3 financial assistance programs for patients using Tasigna:

    Novartis Oncology Universal Co-Pay Program

    Tasigna 3 Months Free Trial Voucher

    Novartis Patient Assistance Foundation

  • Hairy‑Cell Leukemia

    Lumoxiti (moxetumomab pasudotox-tdfk)

    Drug company: AstraZeneca
    844-275-2360

    AstraZeneca Access 360 offers 1 financial assistance program for patients who have been prescribed Lumoxiti:

    Access 360 Lumoxiti Patient Savings Program

  • Juvenile Myelomonocytic Leukemia (JML)

    Vidaza (azacitidine) Injection

    Drug company: Bristol Myers Squibb
    800-861-0048

    Bristol Myers Squibb Access Support offers 1 financial assistance program for patients using Vidaza:

    Bristol Myers Squibb Patient Assistance Foundation

  • Mast‑Cell Leukemia

    Ayvakit (avapritinib) Tablets

    Drug company: Blueprint Medicines
    888-258-7768

    Blueprint Medicines offers 5 financial assistance programs for patients who have been prescribed Ayvakit:

    YourBlueprint Co-Pay Assistance Program

    YourBlueprint Patient Assistance Program

    QuickStart Program

    Coverage Interruption Program

    Ayvakit Dose Exchange Program

    Rydapt (midostaurin) Capsules

    Drug company: Novartis
    800-282-7630

    Novartis Patient Assistance NOW Oncology offers 2 financial assistance programs for patients using Rydapt:

    Novartis Oncology Universal Co-Pay Program

    Novartis Patient Assistance Foundation

Table. Drugs Prescribed for Leukemia

Acute Lymphoblastic Leukemia (ALL)
  • Drug name (generic name)
  • Drug company
  • Indications
  • Patient support services
    Drug name (generic name)
  • Besponsa (inotuzumab ozogamicin) Injection
  • Drug company
  • Pfizer
  • Indications
  • Treatment of relapsed or refractory B-cell precursor ALL
  • Patient support services
  • Pfizer Patient Assistance Program
    877-744-5675
    Drug name (generic name)
  • Kymriah (tisagenlecleucel)
  • Drug company
  • Novartis
  • Indications
  • Treatment of B-cell precursor ALL in patients up to age 25
  • Patient support services
  • Kymriah Cares
    844-459-6742
    Drug name (generic name)
  • Rylaze (asparaginase erwinia chrysanthemi [recombinant]-rywn) Injection
  • Drug company
  • Jazz Pharmaceuticals
  • Indications
  • Treatment of ALL or lymphoblastic lymphoma in patients 1 month or older who have hypersensitivity to E. coli-derived asparaginase
  • Patient support services
  • JazzCares Copay Savings Card
    833-533-5299

    JazzCares Patient Assistance Program
    833-533-5299
    Drug name (generic name)
  • Tecartus (brexucabtagene autoleucel)
  • Drug company
  • Kite Pharma
  • Indications
  • Treatment of adults with relapsed or refractory B-cell precursor ALL
  • Patient support services
  • Kite Konnect
    844-454-5483
Acute Myeloid Leukemia (AML)
  • Drug name (generic name)
  • Drug company
  • Indications
  • Patient support services
    Drug name (generic name)
  • Idamycin PFS (idarubicin hydrochloride)
  • Drug company
  • Pfizer
  • Indications
  • Treatment of AML
  • Patient support services
  • Pfizer Patient Assistance Program
    877-744-5675
    Drug name (generic name)
  • Mylotarg (gemtuzumab ozogamicin) Injection
  • Drug company
  • Pfizer
  • Indications
  • Treatment of CD33-positive AML in adults

    Treatment of relapsed or refractory CD33-positive AML in patients age 2 or older
  • Patient support services
  • Pfizer Patient Assistance Program
    877-744-5675
    Drug name (generic name)
  • Onureg (azacitidine) Tablets
  • Drug company
  • Bristol Myers Squibb
  • Indications
  • Treatment of patients with AML who achieved first complete remission or complete remission with incomplete blood count recovery after intensive induction chemotherapy and who cannot complete intensive curative therapy
  • Patient support services
  • BMS Oncology Co-Pay Assistance Program
    800-861-0048

    Bristol Myers Squibb Patient Assistance Foundation
    800-736-0003
    Drug name (generic name)
  • Rezlidhia (olutasidenib) Capsules
  • Drug company
  • Rigel and Forma Therapeutics, Inc
  • Indications
  • Treatment of adult patients with relapsed or refractory AML with a susceptible IDH1 mutation as detected by an FDA-approved test
  • Patient support services
  • Rigel Onecare

    Rezlidhia Copay Assistance
    833-744-3562
    Drug name (generic name)
  • Tibsovo (ivosidenib) Tablets
  • Drug company
  • Servier Pharmaceuticals
  • Indications
  • First-line treatment of AML with IDH1 mutation in adults 75 or older or patients with comorbidities that preclude intensive chemotherapy

    Treatment of adults with relapsed or refractory AML with IDH1 mutation

    Treatment of patients older than 75 who have comorbidities that preclude use of intensive induction chemotherapy in combination with azacitidine for newly diagnosed AML with susceptible IDH1 mutation
  • Patient support services
  • Tibsovo Co-pay Program
    844-409-1141

    Patient Assistance Program
    844-409-1141
    Drug name (generic name)
  • Vyxeos (daunorubicin & cytarabine) Liposome for Injection
  • Drug company
  • Jazz Pharmaceuticals
  • Indications
  • First-line treatment of therapy-related AML in adults and pediatric patients 1 year or older

    Treatment of AML with myelodysplasia-related changes
  • Patient support services
  • JazzCares Copay Savings Card
    833-533-5299

    JazzCares Patient Assistance Program
    833-533-5299
    Drug name (generic name)
  • Zarxio (filgrastim-sndz) Injection
  • Drug company
  • Sandoz
  • Indications
  • Treatment of AML
  • Patient support services
  • Sandoz One Source Co-Pay Program
    844-726-3691

Chronic Lymphocytic Leukemia (CLL)
  • Drug name (generic name)
  • Drug company
  • Indications
  • Patient support services
    Drug name (generic name)
  • Arzerra (ofatumumab)
  • Drug company
  • Novartis
  • Indications
  • Treatment of CLL, sometimes in combination with chlorambucil, or with fludarabine & cyclophosphamide
  • Patient support services
  • Novartis Patient Assistance Foundation
    800-277-2254
    Drug name (generic name)
  • Gazyva (obinutuzumab)
  • Drug company
  • Genentech
  • Indications
  • First-line treatment of CLL, in combination with Imbruvica

    First-line treatment of CLL, in combination with Venclexta

    Treatment of CLL, in combination with chlorambucil
  • Patient support services
  • Genentech Oncology Co-pay Assistance Program
    855-692-6729

    Genentech Patient Foundation
    888-941-3331
    Drug name (generic name)
  • Imbruvica (ibrutinib) Capsules/Tablets
  • Drug company
  • Pharmacyclics
  • Indications
  • First-line treatment of CLL, with or without 17p deletion

    First-line treatment of CLL, in combination with Gazyva
  • Patient support services
  • Imbruvica Copay Card
    888-968-7743

    Johnson & Johnson Patient Assistance Foundation
    800-652-6227
    Drug name (generic name)
  • Venclexta (venetoclax) Tablets
  • Drug company
  • AbbVie/Genentech
  • Indications
  • Treatment of CLL with or without 17p deletion, after 1 therapy

    First-line treatment of CLL, in combination with Gazyva or with rituximab
  • Patient support services
  • Genentech Oncology Co-pay Assistance Program
    855-692-6729

    Genentech Patient Foundation
    888-941-3331
Chronic Myeloid Leukemia (CML)
  • Drug name (generic name)
  • Drug company
  • Indications
  • Patient support services
Hairy‑Cell Leukemia
  • Drug name (generic name)
  • Drug company
  • Indications
  • Patient support services
    Drug name (generic name)
  • Lumoxiti (moxetumomab pasudotox-tdfk)
  • Drug company
  • AstraZeneca
  • Indications
  • Treatment of relapsed or refractory hairy-cell leukemia after systemic therapy
  • Patient support services
  • Access 360 Lumoxiti Patient Savings Program
    844-275-2360
Juvenile Myelomonocytic Leukemia (JML)
  • Drug name (generic name)
  • Drug company
  • Indications
  • Patient support services
Mast‑Cell Leukemia
  • Drug name (generic name)
  • Drug company
  • Indications
  • Patient support services

Report Broken Links

Have you encountered a problem with a URL (link) on this page not working or displaying an error message?

Help us fix it! Report broken links here.

Report Broken Link